{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:21:41Z","timestamp":1792153301257,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.autrev.2024.103582","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T18:24:40Z","timestamp":1722104680000},"page":"103582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Julien","family":"Guiot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Miedema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska K.","family":"De Vries-Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Tzouvelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.autrev.2024.103582_bb0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0010","doi-asserted-by":"crossref","first-page":"00597","DOI":"10.1183\/23120541.00597-2021","article-title":"Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries","volume":"8","author":"Hilberg","year":"2022","journal-title":"ERJ Open Research"},{"issue":"5","key":"10.1016\/j.autrev.2024.103582_bb0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00408-020-00383-w","article-title":"Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment","volume":"198","author":"Jeganathan","year":"2020","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.autrev.2024.103582_bb0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103582_bb0025","series-title":"2023 American College of Rheumatology (ACR) Guidelines for the treatment of intertstitial lung disease in People with systemic autoimmune rheumatic disease","year":"2023"},{"key":"10.1016\/j.autrev.2024.103582_bb0030","series-title":"2023 American College of Rheumatology (ACR) Guidelines for the Screening and Monitoring of intertstitial lung disease in People with systemic autoimmune rheumatic disease","year":"2023"},{"issue":"165","key":"10.1016\/j.autrev.2024.103582_bb0035","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0003-2022","article-title":"Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives","volume":"31","author":"Cottin","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"10","key":"10.1016\/j.autrev.2024.103582_bb0040","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s10067-019-04720-0","article-title":"Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases","volume":"38","author":"Fischer","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103582_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","article-title":"Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database","volume":"80","author":"Hoffmann-Vold","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"10373","key":"10.1016\/j.autrev.2024.103582_bb0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.autrev.2024.103582_bb0055","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"5","key":"10.1016\/j.autrev.2024.103582_bb0060","doi-asserted-by":"crossref","first-page":"1902026","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.autrev.2024.103582_bb0065","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"5","key":"10.1016\/j.autrev.2024.103582_bb0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.semarthrit.2021.07.018","article-title":"Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: a retrospective cohort study","volume":"51","author":"Vandecasteele","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2024.103582_bb0075","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete Nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.autrev.2024.103582_bb0080","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1513\/AnnalsATS.201806-362OC","article-title":"Does systemic sclerosis-associated interstitial lung disease burn out? Specific phenotypes of disease progression","volume":"15","author":"Guler","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"135","key":"10.1016\/j.autrev.2024.103582_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"European respiratory review\u202f: an official journal of the European Respiratory Society"},{"issue":"3","key":"10.1016\/j.autrev.2024.103582_bb0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/BOR.0000000000000270","article-title":"Management of connective tissue diseases associated interstitial lung disease: a review of the published literature","volume":"28","author":"Wallace","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103582_bb0095","doi-asserted-by":"crossref","first-page":"1024298","DOI":"10.3389\/fmed.2022.1024298","article-title":"Progressive fibrosing interstitial lung disease in rheumatoid arthritis: a retrospective study","volume":"9","author":"Denis","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2 Pt 1","key":"10.1016\/j.autrev.2024.103582_bb0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.autrev.2024.103582_bb0105","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2024.103582_bb0110","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/annrheumdis-2021-220698","article-title":"Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers","volume":"80","author":"Palom\u00e4ki","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.autrev.2024.103582_bb0115","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.autrev.2024.103582_bb0120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"11","key":"10.1016\/j.autrev.2024.103582_bb0125","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1016\/S2665-9913(21)00250-2","article-title":"Current issues in rheumatoid arthritis-associated interstitial lung disease","volume":"3","author":"Kelly","year":"2021","journal-title":"The Lancet Rheumatology"},{"issue":"6","key":"10.1016\/j.autrev.2024.103582_bb0130","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0135","doi-asserted-by":"crossref","first-page":"1800869","DOI":"10.1183\/13993003.00869-2018","article-title":"Predicting outcomes in rheumatoid arthritis related interstitial lung disease","volume":"53","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2024.103582_bb0150","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/17843286.2021.1925818","article-title":"Clinical experience in anti-synthetase syndrome: a monocentric retrospective analytical study","volume":"77","author":"Maloir","year":"2022","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.autrev.2024.103582_bb0155","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study","volume":"8(1):87","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s40674-018-0110-6","article-title":"Myositis-related interstitial lung diseases: diagnostic features, treatment, and complications","volume":"5","author":"Shappley","year":"2019","journal-title":"Current Treatment Options in Rheumatology"},{"issue":"5","key":"10.1016\/j.autrev.2024.103582_bb0165","article-title":"Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and Meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.autrev.2024.103582_bb0170","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","article-title":"Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients","volume":"57","author":"Sato","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2024.103582_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMicm1816147","article-title":"Cutaneous ulcerations in anti-MDA5 dermatomyositis","volume":"381","author":"Charrow","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0180","article-title":"Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype","volume":"2001205","author":"Graham","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13148-020-00915-4","article-title":"A new nucleosomic-based model to identify and diagnose SSc-ILD","volume":"12","author":"Guiot","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"12","key":"10.1016\/j.autrev.2024.103582_bb0190","first-page":"2240","article-title":"The association between MUC5B Rs35705950 and risks of idiopathic interstitial pneumonia, systemic sclerosis interstitial lung disease, and familial interstitial pneumonia: a Meta-analysis","volume":"49","author":"Lou","year":"2020","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.autrev.2024.103582_bb0195","first-page":"203","article-title":"Interstitial lung dis-ease in rheumatoid arthritis remains a challenge for clinicians","volume":"8","author":"Bendstrup","year":"2019","journal-title":"J ClinMed"},{"key":"10.1016\/j.autrev.2024.103582_bb0200","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/rheumatology\/keab552","article-title":"The attitudes and practices of physicians caring for patients with rheumatoid arthritis-interstitial lung disease: an international survey","volume":"61","author":"Solomon","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103582_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","article-title":"Diagnostic accuracy of a Velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device)","volume":"19","author":"Manfredi","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.reuma.2019.05.007","article-title":"Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis","volume":"17","author":"Paulin","year":"2021","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.autrev.2024.103582_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823669","article-title":"Development of a risk nomogram model for identifying interstitial lung disease in patients with rheumatoid arthritis","volume":"13","author":"Xue","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103582_bb0220","first-page":"74","article-title":"Screening criteria for interstitial lung disease associated to rheumatoid arthritis: expert proposal based on Delphi methodology","volume":"19","author":"Narvaez","year":"2023","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"10354","key":"10.1016\/j.autrev.2024.103582_bb0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.autrev.2024.103582_bb0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner society: glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2024.103582_bb0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.rmed.2017.03.027","article-title":"High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival","volume":"126","author":"Yunt","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106579","article-title":"Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases","volume":"187","author":"Chiu","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0245","doi-asserted-by":"crossref","first-page":"105407","DOI":"10.1016\/j.jbspin.2022.105407","article-title":"The emerging role of ultrasound in detecting interstitial lung disease in patients with rheumatoid arthritis","volume":"89","author":"Gutierrez","year":"2024","journal-title":"Joint Bone Spine 022"},{"issue":"9","key":"10.1016\/j.autrev.2024.103582_bb0250","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0255","doi-asserted-by":"crossref","first-page":"1016898","DOI":"10.3389\/fmed.2022.1016898","article-title":"Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease","volume":"9","author":"Panagopoulos","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12890-023-02615-0","article-title":"Application of impulse oscillometry to detect interstitial lung disease and airway disease in adults with rheumatoid arthritis","volume":"23","author":"Cheng","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/406927","article-title":"Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0270","article-title":"Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study","volume":"8","author":"Moran-Mendoza","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"10.1016\/j.autrev.2024.103582_bb0275","doi-asserted-by":"crossref","first-page":"2103187","DOI":"10.1183\/13993003.03187-2021","article-title":"Progressive pulmonary fibrosis: an expert group consensus statement","volume":"61","author":"Rajan","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0280","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12890-021-01569-5","article-title":"Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns","volume":"21","author":"Nieto","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103582_bb0285","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1038\/s41598-022-13474-w","article-title":"Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease","volume":"12","author":"Chen","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.autrev.2024.103582_bb0290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.reuma.2021.12.006","article-title":"Screening criteria for interstitial lung disease associated to rheumatoid arthritis: expert proposal based on Delphi methodology","volume":"19","author":"Narv\u00e1ez","year":"2023","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.autrev.2024.103582_bb0295","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0300","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients withprogressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0305","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10067-023-06623-7","article-title":"Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial","volume":"42","author":"Matteson","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103582_bb0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","article-title":"Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2024.103582_bb0315","doi-asserted-by":"crossref","unstructured":"Raghu G, Montes, SB, Silver RM, et al. Treatment of Systemic Sclerosis\u2013associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med, 209(2), 137\u2013152.","DOI":"10.1164\/rccm.202306-1113ST"},{"key":"10.1016\/j.autrev.2024.103582_bb0320","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.autrev.2024.103582_bb0325","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.autrev.2024.103582_bb0330","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccm.2021.03.013","article-title":"Care delivery models and interstitial lung disease: the role of the specialized center","volume":"42","author":"Fisher","year":"2021","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.autrev.2024.103582_bb0335","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.chest.2020.09.256","article-title":"Essential components of an interstitial lung disease clinic: results from a Delphi survey and patient focus group analysis","volume":"159","author":"Graney","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2024.103582_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.55563\/clinexprheumatol\/d2qz38","article-title":"The added value of a European reference network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET","volume":"40 Suppl 134(5)","author":"Talarico","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103582_bb0345","doi-asserted-by":"crossref","unstructured":"Piette Y, Van den Bossche F, Aerts N et al. Flemish network on rare connective tissues diseases (CTD): patient pathways in systemic sclerosis. First steps taken. Acta Clin Belg, 79:1, 26\u201333.","DOI":"10.1080\/17843286.2023.2280737"},{"issue":"3","key":"10.1016\/j.autrev.2024.103582_bb0350","doi-asserted-by":"crossref","first-page":"2300577","DOI":"10.1183\/13993003.00577-2023","article-title":"The ERS PROFILE.net clinical research collaboration is dedicated to the set-up of an academic network to enhance imaging-based management of progressive pulmonary fibrosis","volume":"62","author":"Guiot","year":"2023","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.autrev.2024.103582_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.autrev.2024.103582_bb0360","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors","volume":"57","author":"McNearney","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2024.103582_bb0365","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.semarthrit.2021.07.018","article-title":"Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: a retrospective cohort study","volume":"51","author":"Vandecasteele","year":"2021","journal-title":"Semin Arthritis Rheum"}],"updated-by":[{"DOI":"10.1016\/j.autrev.2024.103641","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:31:34Z","timestamp":1731490294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1568997224000739"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103582","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103582"}}